Research Grants

Emily’s Entourage (EE) provides critical funding to accelerate research and drug development for new treatments and a cure for people with cystic fibrosis (CF) who do not benefit from the currently available CFTR modulator therapies, with a focus on nonsense mutations. The following key areas of research are supported by EE’s grant program:

1. Mutation-specific small molecule rescue treatments for premature termination codons (PTCs)
2. Genetic therapies for premature termination codons
3. Non-viral vectors for DNA and RNA delivery to lung cells
4. Treatment and prevention of Staphylococcus aureus and other clinically important pathogens in the CF patient
5. Drug repurposing using a systems biology approach
6. Promising early-stage research

Support is available for $100,000 per year (plus 10% for indirect costs). Typically, funding will last for two years. Continuation of funding is contingent on progress, which is reported every six months. Contract terms and conditions can be viewed here. 

Applicant Eligibility Criteria

Applicants must have a faculty appointment at an academic institution; a PhD, MD, or DO; and a track record of publication and funding. There are no restrictions on citizenship or geography. 

Deadline

Applications are due by June 30, 2022, at 11:59 p.m. PT.

Please review the 2022 grant application guidelines for complete submission requirements. 

Additional Information

EE also advances research and therapeutic development with strategic investments made through a venture philanthropy model. If you have any questions or would like to discuss your interest in EE’s funding opportunities, please feel free to contact us below.